SILEXION THERAPEUTICS CORP Interest and Dividend Income, Operating
SILEXION THERAPEUTICS CORP (SLXN) reported Interest and Dividend Income, Operating of $14.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestAndDividendIncomeOperating · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP interest and dividend income, operating for the quarter ending 2026-06-30 was $14.00K, a 68.18% decline year-over-year.
- SILEXION THERAPEUTICS CORP interest and dividend income, operating for the quarter ending 2026-03-31 was $32.00K, a 1500.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP interest and dividend income, operating for the quarter ending 2025-12-31 was $69.00K, a 2200.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP interest and dividend income, operating for the quarter ending 2025-09-30 was $39.00K.
| Period end | Interest and Dividend Income, Operating 3 month | Interest and Dividend Income, Operating 6 month | Interest and Dividend Income, Operating 9 month | Interest and Dividend Income, Operating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00K 10-Q · filed 2026-08-14 | $46.00K 10-Q · filed 2026-08-14 | $115.00K derived: sum of 3 quarters · filed 2026-08-14 | $154.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $32.00K S-1/A · filed 2026-08-10 | $101.00K derived: sum of 2 quarters · filed 2026-08-10 | $140.00K derived: sum of 3 quarters · filed 2026-08-10 | $184.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $69.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $108.00K derived: sum of 2 quarters · filed 2026-08-10 | $152.00K derived: sum of 3 quarters · filed 2026-08-14 | $155.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-12 | $83.00K derived: sum of 2 quarters · filed 2026-08-14 | $86.00K 10-Q · filed 2025-11-12 | $88.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $44.00K 10-Q · filed 2026-08-14 | $46.00K 10-Q · filed 2026-08-14 | $49.00K derived: sum of 3 quarters · filed 2026-08-14 | $49.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.00K S-1/A · filed 2026-08-10 | $5.00K derived: sum of 2 quarters · filed 2026-08-10 | $5.00K derived: sum of 3 quarters · filed 2026-08-10 | $11.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $3.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $3.00K derived: sum of 2 quarters · filed 2026-08-10 | $9.00K derived: sum of 3 quarters · filed 2026-08-10 | $28.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $6.00K derived: sum of 2 quarters · filed 2025-11-12 | $25.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-12 | $25.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $19.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $153.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |